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BACKGROUND: Few studies have examined epidemiological differences between ethnic groups for children and young adults with
cancer.
METHODS: Subjects aged 0–29 years, diagnosed between 1990 and 2005 in the former Yorkshire Regional Health Authority, were
included in the analysis. Ethnicity (south Asian or not) was assigned using name analysis program and Hospital Episode Statistics
data. Differences in incidence (per 1000000 person-years) rates and trends were analysed using joinpoint and Poisson regression
analysis.
RESULTS: Overall cancer incidence was similar for south Asians (12.1, 95% CI: 10.7–13.5; n¼275) and non-south Asians (12.6, 95%
CI: 12.2–13.1; n¼3259). Annual incidence rates increased significantly by 1.9% per year on average (95% CI: 1.2–2.6%), especially
for south Asians (7.0%; 95% CI: 4.2–9.9%).
CONCLUSION: If present trends continue, the higher rate of increase seen among south Asians aged 0–29 years in Yorkshire will result
in three times higher cancer incidence than non-south Asians by 2020.
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Within Europe and the United Kingdom, several cancer epide-
miology studies have shown differences in incidence rates between
ethnic groups across all ages (Lane et al, 2007; Jack et al, 2009;
NCIN, 2009). Differences in incidence by ethnic group have also
been observed amongst children (0–14 year olds) in the United
Kingdom. Excesses of all cancers combined and of leukaemia,
acute myeloid leukaemia, lymphoma, germ cell and hepatic
cancers has been observed amongst south Asians compared with
non-south Asians over the last 20 years (Powell et al, 1994; Winter
et al, 1999; Cummins et al, 2001; McKinney et al, 2003). However,
south Asian children have displayed lower incidence rates of
Wilms’ tumours and rhabdomyosarcoma (Stiller et al, 1991; Powell
et al, 1994). Furthermore, the well-described incidence peak for
leukaemia amongst 2–6 year olds has been observed later in life
for south Asians (5–9 year olds) than for non-south Asians (0–4
year olds) (McKinney et al, 2003; McNally and Eden, 2004). In the
United States, incidence of leukaemia was higher among Hispanics
and lower amongst Blacks, compared with White children and
adolescents (Bleyer, 2002; Matasar et al, 2006). Although the
descriptive epidemiology of teenage and young adult cancer in the
United Kingdom has been the subject of recent studies, none have
focused on differences by ethnic group (Birch et al, 2003, 2008).
Moreover, it is unclear whether incidence differences exist
exclusively in the older adult population or whether they begin
to emerge in adolescence or young adulthood.
We have investigated for the first time in the United Kingdom
incidence trends in Yorkshire by ethnic group (south Asian or not)
across the childhood (0–14 years) and young adult (15–29 years)
age ranges, exploiting the availability of population-based data and
using information on ethnic group derived and validated using a
combination of two name analysis programs and linked hospital
episode statistics (HES) data.
MATERIALS AND METHODS
The data used for this study were extracted from the Yorkshire
Specialist Register of Cancer in Children and Young People
(YSRCCYP), a population-based data set of children (aged 0–14
years) and young adults (aged 15–29 years) diagnosed with cancer
while residing in the former Yorkshire Regional Health Authority
since 1974 (Feltbower et al, 2009). Patients were eligible if
diagnosed between 1990 and 2005 and aged between 0 and 29
years. Skin carcinomas and melanomas were excluded. Case details
were ascertained from hospital clinics and neuropathology
departments across the region, and additional ascertainment
checks undertaken for completeness were carried out with the
National Registry of Childhood Tumours (www.ccrg.ox.ac.uk) and
the Northern and Yorkshire Cancer Registry and Information
Service (www.nycris.org.uk). A total of 85% of all diagnoses
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(Feltbower et al, 2009).
Tumour diagnoses were categorised into histological groups
according to the International Classification of Childhood Cancer
(ICCC) (Krama ´rova ´ et al, 1996). For the purposes of certain
analyses, malignancies were also grouped into the following four
categories to retain statistical power: leukaemia, lymphoma,
central nervous system (CNS) tumours and other solid tumours,
corresponding to ICCC codes I, II, III and IV–XII.
The former Yorkshire region contained a population of B1.4
million 0–29 year olds at the time of the 2001 census, 8% of who
were of south Asian ethnic origin. This was an increase of 1.5% in
the south Asian population since 1991. In 2001, the study area
contained 11% of all 0- to 29-year-old south Asians in England,
compared with only 7.4% of all 0- to 29-year-old non-south Asians.
Historically, in the United Kingdom, cancer registry data on
ethnic group has not been routinely or accurately, collected and
thus alternative methods have been proposed to allocate ethnicity.
Ethnicity was assigned as either south Asian (i.e., of Pakistani,
Indian or Bangladeshi origin) or non-south Asian (all other
ethnicities) initially using the south Asian names analysis program
Nam Pehchan and the South Asian Name and Group Recognition
Algorithm (SANGRA), with visual inspection by local experts in
case of any discrepancy. Both programs have a high level of
accuracy and Nam Pehchan is particularly suited to the south
Asian population of Yorkshire (Cummins et al, 1999; Nanchahal
et al, 2001).
In addition to both name analysis programs, independent
crosschecking was completed using ethnicity data available from
linked in-patient HES data. The HES records were matched
through NHS number, date of birth, postcode and sex. A total of
62% (N¼2195) of registered patients were successfully linked to at
least one HES record and no ethnic group was recorded in HES for
24% (N¼517) of the linked patients; thus, 1678 (47.5%) patients’
ethnic classification derived from Nam Pehchan and/or SANGRA
included in the analysis were validated using HES. For every
hospital episode, ethnicity details are collected separately, which
can lead to an individual being allocated multiple ethnicity codes.
The most frequently recorded ethnicity code was used to overcome
this issue, if present. Ethnicity codes within HES are based on the
16 categories, as used in the 2001 census. These groups were
aggregated to a binary classification of south Asian and non-south
Asian. In cases in which the most common code was listed as
‘unknown’, the most commonly occurring known group was used
instead.
Where clear differences existed between the original 16-category
HES code and the name analysis (e.g. White British vs south
Asian), HES superseded the name analysis classification and
the data were changed accordingly. However, in cases in which the
HES ethnicity code was ambiguous, such as ‘any other Asian’ or
‘any other ethnic group’, compared with a name classification of
south Asian, the latter ethnicity assignment was retained. There
was disagreement between assigned ethnicity based on HES data
and name analysis in just 2.4% (n¼40) of cases, of which 23 were
re-allocated.
Statistical analysis
Incidence rates and trends were examined overall and by major
histological subtype. Internally, age- and sex-standardised inci-
dence rates (per 1000000 person-years) and 95% confidence
intervals by ethnic group were calculated using mid-year popula-
tion estimates of the former Yorkshire Regional Health Authority
based on the 1991 and 2001 UK census available by single year of
age, sex and ethnic group. Population estimates used between 1990
and 2001 incorporated non-responses that were not included in the
original UK census estimates; these figures also take into account
changes in census geographies over time (Norman et al, 2008;
Sabater and Simpson, 2009). Mid-year population estimates from
2002 to 2005 were experimental estimates by ethnic group
provided by the Office for National Statistics (ONS, 2001 Census).
Incidence rates were calculated by 5-year age band (0–4, 5–9,
10–14, 15–19, 20–24 and 25–29 years), diagnostic group and
gender. Incidence trends were assessed by deriving smoothed
3-year moving averages (MA) for the study period in order to
highlight temporal patterns within the data. Initially, joinpoint
regression was used to compare differences in the incidence of
cancer between south Asian and non-south Asian children and
young people, while adjusting for sex, age and year of diagnosis.
Poisson regression models were used when joinpoint analysis
provided no evidence against a constant average annual percentage
change (AAPC) in incidence rates. An interaction term between
year and ethnic group was included in the best fitting model to
assess whether the effect of ethnic group changed significantly over
time. Incidence trends by ethnicity were forecasted up to 2020
by extrapolating predicted values from the final model. Statistical
analyses were implemented mostly in Stata 11 (StataCorp, 2009);
joinpoint regression was performed using the Joinpoint Regression
Program version 3.4.3 (National Cancer Institute, 2010).
RESULTS
A total of 3534 children and young adults were registered with a
tumour between 1990 and 2005 while living in the former
Yorkshire region, of whom 275 (7.8%) were south Asian.
The number of cases, comparative frequencies and age- and sex-
standardised incidence rates by diagnostic group, age group and
gender for south and non-south Asians are given in Table 1. The
distribution of cases was very similar across ethnic groups, except
for a higher frequency of 25- to 29-year-old non-south Asian cases
compared with south Asians. There was a notable excess of male
cases compared with females, which was similar across ethnic
groups. The incidence rate (per 1000000 person-years) for all
cancers in 0–29 year olds between 1990 and 2005 was 12.6 (95%
CI: 12.2–13.0) and was similar overall between ethnic groups.
Rates were non-significantly higher for south Asians with
leukaemia and lymphoma, but were lower for CNS and other
solid tumours. Slightly higher rates for all cancers combined were
observed in south Asian for those aged 5–9, 10–14 and 15–19
years; however, this was not significant. There was no significant
difference in incidence when comparing male and female south
Asians and non-south Asians for all tumour groups combined.
Age-specific incidence rates by ethnic group for each diagnostic
group are given in figure A of the Supplementary Material. A small
deficit amongst 25- to 29-year-old south Asians compared with
non-south Asians was seen consistently across all diagnostic
groups, and was most evident amongst lymphomas and CNS
tumours.
Poisson regression models showed that there was a significant
difference between the incidence rates of south and non-south
Asians by diagnostic group (likelihood-ratio test for ethnic group
and diagnostic group interaction; P¼0.01), adjusting for age
group, sex and year of diagnosis. No significant difference in
incidence between age group and ethnicity was apparent when
testing for an interaction between the two variables.
Figure 1 displays incidence trends between 1990 and 2005 for all
cancers combined and for each diagnostic group using smoothed
3-year MA. Joinpoint regression analysis revealed that the best
fitting model for all cancers combined and for each diagnostic
group was one with no joinpoints; therefore, Poisson regression
was used to calculate the AAPC in each case. Overall, there was a
significant AAPC of 1.9% (95% CI: 1.2–2.6%; P-value o0.001). A
significant change in incidence was also seen for leukaemia
(AAPC¼1.8%; 95% CI: 0.2–3.4%; P-value¼0.027) and other
solid tumours (AAPC¼2.9%; 95% CI: 1.7–4.1%; P-value o0.001).
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bone tumours (4.3%; n¼151), germ cell neoplasms (4.4%;
n¼614) and carcinomas (5%; n¼94). No significant change in
incidence was apparent for lymphoma (1.1%) or CNS (1.0%)
tumours.
Likelihood-ratio tests showed significant differences between the
temporal change in incidence by ethnic group (an interaction
between year and ethnicity) for all cancers combined (P¼0.0002).
Joinpoint regression analysis again showed that the best fitting
model in each case for both south and non-south Asians had no
joinpoints, and thus the AAPC was calculated using Poisson
regression. The rate of increase among south Asians was much
higher (AAPC¼7%; 95% CI: 4.2–9.9%) compared with non-south
Asians (AAPC 1.5%; 95% CI: 0.8–2.3%); this finding was even
more pronounced for the south Asians aged 15–29 years
(AAPC¼11%; 95% CI: 4.0–18.0%). Similarly, there was a
significantly higher rate of increase for south Asians with
lymphoma (AAPC 12.0%; 95% CI: 5–18%) compared with non-
south Asians (AAPC 0.1%; 95% CI:  1.5 to 1.7%), although the
number of south Asians with lymphoma between 1990 and 2000
was extremely small (n¼28). This meant that rates of all cancers
combined among south Asians matched those of the indigenous
population by 2005, despite exhibiting much lower rates before the
mid-1990s (Figure 1). This difference in incidence trends by ethnic
group was not mirrored among those with leukaemia, CNS
tumours or other solid tumours.
Temporal incidence rates comparing 0–14 and 15–29 year olds
by diagnostic group showed a significant increase in incidence
rates for 15–29 year olds between 1990 and 2005 for all cancers
combined (AAPC¼2.9%; 95% CI: 2.0–3.9%), leukaemia
(AAPC¼4.2%; 95% CI: 1.3–7.1%) and other solid tumours
(AAPC¼4.4%; 95% CI: 3.0–5.9%). No significant change in
incidence was apparent for 0–14 year olds (0.01% for all cancers
combined).
Figure 2 shows the age- and sex-standardised incidence rates for
south and non-south Asians for all cancers combined alongside
predicted incidence rates from 2005 to 2020. If the AAPC continues
to increase at a constant rate, the incidence of cancer amongst
south Asians is set to increase by almost threefold from 2005
onwards to be B56 per million compared with 17 per million for
non-south Asians by 2020.
DISCUSSION
We report details of the first population-based epidemiological
study looking at incidence rates and trends across the childhood,
teenage and young adult age range using a validated ethnic group
classification. Previous epidemiological studies focusing on ethnic
minority populations have relied on a single source of data on
ethnic group (Cummins et al, 2001; McKinney et al, 2003).
However, our analysis incorporated information from the patient’s
name alongside a self-reported ethnic classification derived from
routine hospital admissions. Although we were able to validate
only half of the cohort using this data source, misclassification
rates were extremely low, suggesting that the primary methodology
based on name recognition software algorithms was an accurate
and reliable approach. An estimated 60% of the south Asian
population within the study region (mainly West Yorkshire)
originates from Mirpur in rural Pakistan, making it one of the few
regions in the United Kingdom that allows for a detailed analysis
of a relatively homogeneous south Asian population (Turton and
Gonza ´les, 1999; The Change Institute, Department for Commu-
nities and Local Government, 2009). We used mid-year population
estimates broken down by age, sex and crucially by ethnic group.
These were derived from recent research to enhance previous
census and mid-year estimates with adjustments for differential
non-response by age–sex and ethnic group and on the most recent
ONS estimates. We are therefore confident in the accuracy of our
population denominator and ethnic group assignment.
We found a significantly higher rate of increase in incidence
among the south Asian population of Yorkshire in comparison
with non-south Asians, which resulted in similar overall incidence
rates between ethnic groups across the study period (1990–2005).
This difference in incidence trends was apparent for all cancers
combined, but most pronounced for lymphoma, and seen in
particular among 15–29 year olds.
Our findings suggest that there may be an aetiological
component, possibly environmental in nature, which could be
specific to the context of the south Asian population in Yorkshire.
Other epidemiological studies focusing on chronic disease
epidemiology in Yorkshire have suggested that there may be a
dietary (Edwards et al, 2006) or infectious (Parslow et al, 2001;
Feltbower et al, 2005) component to aetiology and future work
Table 1 Number of cases and age–sex standardised incidence rates for south Asians and non-south Asians by diagnostic group, age group and gender
(1990–2005)
Number of cases Incidence rates
South Asian,
cases (column %)
Non-south Asian,
cases (column %) Total
South Asian,
rate (95% CI)
Non-south Asian,
rate (95% CI) P-value
Diagnostic group
Leukaemia 66 (24) 649 (20) 715 33.6 (25.4–41.7) 30.3 (27.9–32.6) 0.354
Lymphoma 71 (26) 689 (21) 760 37.8 (28.9–46.6) 31.9 (29.5–34.3) 0.074
CNS tumours 37 (13) 562 (17) 599 19.4 (13.1–25.7) 26.1 (24.0–2.83) 0.111
Other solid cancers 101 (37) 1359 (42) 1460 6.1 (4.9–7.3) 7.0 (6.6–7.4) 0.191
Age at diagnosis (years)
0–4 66 (24) 650 (20) 716 16.2 (12.3–20.1) 16.1 (14.8–17.3) 0.918
5–9 40 (15) 364 (11) 404 10.5 (7.2–13.8) 8.5 (7.7–9.4) 0.225
10–14 37 (13) 375 (12) 412 10.5 (7.1–13.9) 8.7 (7.9–9.6) 0.28
15–19 42 (15) 463 (14) 505 11.3 (7.9–14.7) 10.9 (9.9–11.9) 0.723
20–24 41 (15) 597 (18) 638 10.4 (7.2–13.6) 13.4 (12.3–14.5) 0.181
25–29 49 (18) 810 (25) 859 14.2 (10.2–18.2) 18.1 (16.8–19.3) 0.146
Gender
Male 159 (58) 1995 (61) 2154 14.2 (12.0–16.4) 15.3 (14.6–15.9) 0.555
Female 116 (42) 1264 (39) 1380 10.0 (8.2–11.8) 9.9 (9.4–10.5) 0.744
Total 275 3259 3534 12.1 (10.7–13.5) 12.6 (12.2–13.1) 0.801
Abbreviations: CI¼confidence interval; CNS¼central nervous system.
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group, to identify plausible causal hypotheses. The temporal
variation in incidence trends by ethnic group could, in part, be
confounded by socioeconomic status (Varghese et al, 1996) or
genetic differences between Mirpuri south Asians and other ethnic
groups (De Vos et al, 2006). We plan to examine ethnicity with
respect to socioeconomic status in a further detailed ecological
analysis.
The differential increase in incidence among the south Asian
population also has implications for healthcare resource planners
in the region. Our incidence projections suggest the burden of
disease for south Asians is likely to result in almost three times
higher rates by 2020, assuming that the linear increase since 1990
continues and the age structure of the Yorkshire population
remains the same over time. The highest proportion of south
Asians reside within the highly urbanised district of Bradford in
West Yorkshire, comprising 48% of the total south Asian
population of Yorkshire, and it is here that the increase in the
burden of disease on the NHS will be most strongly felt.
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Figure 1 Smoothed (3-year moving average) age- and sex-standardised incidence rates (IR) by ethnic group in Yorkshire, UK (1990–2005).
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Figure 2 Age- and sex-standardised incidence rates (IR) and predicted
rates by ethnic group for all cancers combined.
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among south Asians, but a deficit for CNS tumours and other solid
tumours. This supports findings from previous UK childhood
investigations (Stiller et al, 1991; Powell et al, 1994; Winter et al,
1999; Cummins et al, 2001; McKinney et al, 2003). Studies that looked
at the older childhood and young adult age range revealed similar
temporal increases in incidence, which was more pronounced among
the other solid tumour groups, particularly melanoma and carcinoma
(Birch et al, 2002; Reedijk et al, 2005; Kroll et al,2 0 0 6 ) .M o r er e c e n t l y ,
these changes in incidence could, in part, be attributed to
improvements in diagnostic techniques and better case ascertain-
ment, although the latter is unlikely because of annual crosschecks
with other regional and national cancer registries and neuropathology
databases since the early 1990s (see Materials and Methods), while
histological verification of tumours has exceeded 85%.
In summary, despite the similarity in incidence rates between
south Asian and non-south Asians in Yorkshire, our data revealed
a sharper increase for the south Asian population, which, if present
trends persist, will result in a threefold higher incidence by 2020
compared with non-south Asians.
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